| Leuprorelin |
20070097 |
ELIGARD, Solution for injection, 22.5, mg, Pack: 1 |
Astellas Pharma d.o.o, Словения |
Astellas Pharma Europe B.V., The Netherlands |
324.22 |
64.84 |
389.06 |
4% |
10 |
334.22 |
66.84 |
401.06 |
16% |
25 |
359.22 |
71.84 |
431.06 |
цената е заличена с решение НСР-6529/24.06.2015 (в сила от 16.07.2015 ) |
НСР-6227/21.05.2015 |
04.06.2015 |
04.06.2015 |
Заличен |
3200 |
| Leuprorelin |
20060216 |
ELIGARD, Solution for injection, 7.5, mg, Pack: 1 |
Astellas Pharma d.o.o, Словения |
Astellas Pharma Europe B.V., The Netherlands |
137.65 |
27.53 |
165.18 |
4% |
5.51 |
143.16 |
28.63 |
171.79 |
16% |
22.02 |
165.18 |
33.04 |
198.22 |
|
НСР-4652/25.09.2014 |
09.10.2014 |
09.10.2014 |
Неактивен |
3201 |
| Leuprorelin |
20070097 |
ELIGARD, Solution for injection, 22.5, mg, Pack: 1 |
Astellas Pharma d.o.o, Словения |
Astellas Pharma Europe B.V., The Netherlands |
354.46 |
70.89 |
425.35 |
4% |
10 |
364.46 |
72.89 |
437.35 |
16% |
25 |
389.46 |
77.89 |
467.35 |
|
НСР-4653/25.09.2014 |
09.10.2014 |
09.10.2014 |
Неактивен |
3200 |
| Leuprorelin |
20070097 |
ELIGARD, Powder and solvent for solution for injection, 45, mg, Pack: 1 |
Astellas Pharma d.o.o, Словения |
Astellas Pharma Europe B.V., The Netherlands |
708.75 |
141.75 |
850.5 |
4% |
10 |
718.75 |
143.75 |
862.5 |
16% |
25 |
743.75 |
148.75 |
892.5 |
корекц решение НСР-3225/14.04.2014 |
НСР-2509/24.01.2014 |
21.03.2014 |
21.03.2014 |
Неактивен |
3859 |
| Leuprorelin |
20070097 |
ELIGARD, Solution for injection, 22.5, mg, Pack: 1 |
Astellas Pharma d.o.o, Словения |
Astellas Pharma Europe B.V., The Netherlands |
371.43 |
74.29 |
445.72 |
4% |
10 |
381.43 |
76.29 |
457.72 |
16% |
25 |
406.43 |
81.29 |
487.72 |
промяна на обстоятелства НСР-934/12.08.2013 |
НСР-447/09.07.2013 |
30.07.2013 |
30.07.2013 |
Неактивен |
3200 |
| Leuprorelin |
20060216 |
ELIGARD, Solution for injection, 7.5, mg, Pack: 1 |
Astellas Pharma d.o.o, Словения |
Astellas Pharma Europe B.V., The Netherlands |
150.4 |
30.08 |
180.48 |
4% |
6.02 |
156.42 |
31.28 |
187.7 |
16% |
24.06 |
180.48 |
36.1 |
216.58 |
промяна на обстоятелства НСР-934/12.08.2013 |
НСР-455/09.07.2013 |
30.07.2013 |
30.07.2013 |
Неактивен |
3201 |
| Leuprorelin |
20070097 |
ELIGARD, Powder and solvent for solution for injection, 45, mg, Pack: 1 |
Astellas Pharma d.o.o, Словения |
Astellas Pharma Europe B.V., The Netherlands |
762.09 |
152.42 |
914.51 |
4% |
10 |
772.09 |
154.42 |
926.51 |
16% |
25 |
797.09 |
159.42 |
956.51 |
промяна на обстоятелства НСР-2798/17.02.2014 |
КЦРР-2922/20.03.2013 |
18.04.2013 |
18.04.2013 |
Неактивен |
3859 |
| Leuprorelin |
15058/ 01.12.2006 |
ELIGARD, Solution for injection, 22.5, mg, Pack: 1 |
Astellas Pharma Europe B.V., Нидерландия |
Medigene AG, Germany |
454.65 |
90.93 |
545.58 |
4% |
10 |
464.65 |
92.93 |
557.58 |
16% |
25 |
489.65 |
97.93 |
587.58 |
|
КЦРР-697/05.06.2012 |
24.06.2012 |
24.06.2012 |
Неактивен |
3200 |
| Leuprorelin |
15057/ 01.12.2006 |
ELIGARD, Solution for injection, 7.5, mg, Pack: 1 |
Astellas Pharma Europe B.V., Нидерландия |
Medigene AG, Germany |
155.74 |
31.15 |
186.89 |
4% |
6.23 |
161.97 |
32.39 |
194.36 |
16% |
24.92 |
186.89 |
37.38 |
224.27 |
|
КЦРР-697/05.06.2012 |
24.06.2012 |
24.06.2012 |
Неактивен |
3201 |
| Leuprorelin |
15058/01.12.2006 |
ELIGARD, Solution for injection, 22.5, mg, Pack: 1 |
Astellas Pharma Europe B.V., Нидерландия |
Medigene AG, Germany |
506.56 |
101.31 |
607.87 |
6% |
15 |
521.56 |
104.31 |
625.87 |
18% |
30 |
551.56 |
110.31 |
661.87 |
|
КЦ-234/29.09.2008 |
31.10.2008 |
31.10.2008 |
Неактивен |
3200 |
| Leuprorelin |
15057/01.12.2006 |
ELIGARD, Solution for injection, 7.5, mg, Pack: 1 |
Astellas Pharma Europe B.V., Нидерландия |
Medigene AG, Germany |
177.32 |
35.46 |
212.78 |
6% |
10.64 |
187.96 |
37.59 |
225.55 |
18% |
30 |
217.96 |
43.59 |
261.55 |
|
КЦ-234/29.09.2008 |
31.10.2008 |
31.10.2008 |
Неактивен |
3201 |
| Apixaban |
EU/1/11/619/003 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Ирландия |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
105.48 |
21.1 |
126.58 |
4% |
4.22 |
109.7 |
21.94 |
131.64 |
16% |
16.88 |
126.58 |
25.32 |
151.9 |
Промяна на обстоятелства НСР-20070/30.10.2019 |
НСР-8984/14.04.2016; НСР-11278/22.12.2016 г.; НСР-14311/26.10.2017 |
10.11.2017 |
02.12.2019 |
Активен |
3266 |
| Apixaban |
EU/1/11/619/003 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
105.48 |
21.1 |
126.58 |
4% |
4.22 |
109.7 |
21.94 |
131.64 |
16% |
16.88 |
126.58 |
25.32 |
151.9 |
|
НСР-8984/14.04.2016; НСР-11278/22.12.2016 г.; НСР-14311/26.10.2017 |
10.11.2017 |
02.12.2017 |
Неактивен |
3266 |
| Apixaban |
EU/1/11/691/009 |
ELIQUIS, Film coated tablet, 5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Ирландия |
Bristol-Myers Squibb S.R.L., Италия |
105.61 |
21.12 |
126.73 |
4% |
4.22 |
109.83 |
21.97 |
131.8 |
16% |
16.9 |
126.73 |
25.35 |
152.08 |
Промяна на обстоятелства НСР-20070/30.10.2019 |
НСР-8332/26.02.2016; НСР-11063/01.12.2016; НСР-13857/14.09.2017; НСР-17256/14.11.2018 |
29.11.2018 |
02.12.2019 |
Активен |
2819 |
| Apixaban |
EU/1/11/691/009 |
ELIQUIS, Film coated tablet, 5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L., Италия |
105.61 |
21.12 |
126.73 |
4% |
4.22 |
109.83 |
21.97 |
131.8 |
16% |
16.9 |
126.73 |
25.35 |
152.08 |
|
НСР-8332/26.02.2016; НСР-11063/01.12.2016; НСР-13857/14.09.2017; НСР-17256/14.11.2018 |
29.11.2018 |
02.12.2018 |
Неактивен |
2819 |
| Apixaban |
EU/1/11/691/009 |
ELIQUIS, Film coated tablet, 5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L., Италия |
107.51 |
21.5 |
129.01 |
4% |
4.3 |
111.81 |
22.36 |
134.17 |
16% |
17.2 |
129.01 |
25.8 |
154.81 |
|
НСР-8332/26.02.2016; НСР-11063/01.12.2016; НСР-13857/14.09.2017 |
29.09.2017 |
02.10.2017 |
Неактивен |
2819 |
| Apixaban |
EU/1/11/619/003 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
106.51 |
21.3 |
127.81 |
4% |
4.26 |
110.77 |
22.15 |
132.92 |
16% |
17.04 |
127.81 |
25.56 |
153.37 |
|
НСР-8984/14.04.2016; НСР-11278/22.12.2016 г. |
02.02.2017 |
02.02.2017 |
Неактивен |
3266 |
| Apixaban |
EU/1/11/691/009 |
ELIQUIS, Film coated tablet, 5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L., Италия |
108.94 |
21.79 |
130.73 |
4% |
4.36 |
113.3 |
22.66 |
135.96 |
16% |
17.43 |
130.73 |
26.15 |
156.88 |
|
НСР-8332/26.02.2016; НСР-11063/01.12.2016 |
02.01.2017 |
02.01.2017 |
Неактивен |
2819 |
| Apixaban |
EU/1/11/619/003 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
107.16 |
21.43 |
128.59 |
4% |
4.29 |
111.45 |
22.29 |
133.74 |
16% |
17.15 |
128.6 |
25.72 |
154.32 |
|
НСР-8984/14.04.2016 |
30.04.2016 |
30.04.2016 |
Неактивен |
3266 |
| Apixaban |
EU/1/11/691/009 |
ELIQUIS, Film coated tablet, 5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L., Италия |
110.56 |
22.11 |
132.67 |
4% |
4.42 |
114.98 |
23 |
137.98 |
16% |
17.69 |
132.67 |
26.53 |
159.2 |
|
НСР-8332/26.02.2016 |
16.03.2016 |
16.03.2016 |
Неактивен |
2819 |
| Apixaban |
EU/1/11/619/003 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
107.16 |
21.43 |
128.59 |
4% |
4.29 |
111.45 |
22.29 |
133.74 |
16% |
17.15 |
128.6 |
25.72 |
154.32 |
|
НСР-8984/14.04.2016 |
30.04.2016 |
30.04.2016 |
Неактивен |
3266 |
| Apixaban |
EU/1/11/691/009 |
ELIQUIS, Film coated tablet, 5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L.,Италия |
110.56 |
22.11 |
132.67 |
4% |
4.42 |
114.98 |
23 |
137.98 |
16% |
17.69 |
132.67 |
26.53 |
159.2 |
|
НСР-8332/26.02.2016 |
16.03.2016 |
16.03.2016 |
Неактивен |
2819 |
| Apixaban |
EU/1/11/691/009 |
ELIQUIS, Film coated tablet, 5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L.,Италия |
110.56 |
22.11 |
132.67 |
4% |
4.42 |
114.98 |
23 |
137.98 |
16% |
17.69 |
132.67 |
26.53 |
159.2 |
|
НСР-8332/26.02.2016 |
16.03.2016 |
16.03.2016 |
Неактивен |
2819 |
| Apixaban |
EU/1/11/619/003 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
107.16 |
21.43 |
128.59 |
4% |
4.29 |
111.45 |
22.29 |
133.74 |
16% |
17.15 |
128.6 |
25.72 |
154.32 |
|
НСР-8984/14.04.2016 |
30.04.2016 |
30.04.2016 |
Неактивен |
3266 |
| Apixaban |
EU/1/11/619/003 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
108.88 |
21.78 |
130.66 |
4% |
4.36 |
113.24 |
22.65 |
135.89 |
16% |
17.42 |
130.66 |
26.13 |
156.79 |
|
НСР-6847/30.07.2015. |
14.08.2015 |
14.08.2015 |
Неактивен |
3266 |